Human Genome Epidemiology Literature Finder
|
Records 1 - 3 (of 3 Records) |
| Query Trace: Pancreatic Neoplasms and CYP3A4[original query] |
|---|
| Pharmacokinetic properties of two erlotinib 150 mg formulations with a genetic effect evaluation in healthy Korean subjects. Clinical drug investigation 2015 Jan 35 (1): 31-43. Choi Hyun-Gyu, Jeon Ji-Young, Im Yong-Jin, Kim Yunjeong, Song Eun-Kee, Seo Young-Hwan, Cho Seok-Je, Kim Min-G |
| Risk factors for erlotinib-induced hepatotoxicity: a retrospective follow-up study. BMC cancer 2018 10 18 (1): 988. Kim Min Kyoung, Yee Jeong, Cho Yoon Sook, Jang Hong Won, Han Ji Min, Gwak Hye S |
| Factors affecting high-grade hepatotoxicity of tyrosine kinase inhibitors in cancer patients: a multi-center observational study. European journal of clinical pharmacology 2020 May . Han Ji Min, Han Hye Won, Yee Jeong, Kim Min Kyoung, Moon Jin Young, Cho Soyeon, Jung Dasom, Cho Yoon Sook, Seo Inyoung, Kim Jae Youn, Gwak Hye S |
- Page last reviewed:Feb 1, 2024
- Content source: